haktutscoinmaster50freespins| Shuyu Civilian (301017.SZ): Net profit for the first quarter of 2024 was 10.51 million yuan, a year-on-year decrease of 83.72%

On April 27, 2024, Shuyu civilians (301017Haktutscoinmaster50freespins.SZ) release the first quarter 2024 results report.

The company realized operating income of 2.439 billion yuan, an increase of 17.69% over the same period last year, and a net profit of 10.51 million yuan, a decrease of 83.72% over the same period last year.Haktutscoinmaster50freespinsThe net cash flow was 75.18 million yuan, an increase of 32.89% over the same period last year, and the asset-liability ratio was 75.28%, up 4.24% from the same period last year.

The company's gross profit margin on sales was 27.27%, down 1.80 percentage points from the same period last year, achieving basic earnings per share of 0.03 yuan, down 81.25% from the same period last year, and the rate of return on diluted net assets was 0.46%, down 2.35 percentage points from the same period last year.

The company's inventory turnover rate was 0.84 times, up 0.08 times from the same period last year, and the total asset turnover rate was 0.26 times, down 0.00 times from the same period last year.

The advance payment of the company is about 6.36 million yuan, the sales cost is about 524 million yuan, the management cost is about 73.72 million yuan, and the financial cost is about 36.79 million yuan.

The number of shareholders of the company is 10, 000, and the top 10 shareholders hold 353 million shares, accounting for 87.17% of the total share capital. The top ten shareholders are Li Wenjie, Qin Guangxia, Jinan Shuyu Jinyun Investment Partnership (Limited Partnership), Jinan Shu Yutong Cheng Investment Partnership (Limited Partnership), Ali Health Technology (China) Co., Ltd., Jinan Shu Yujinyang Investment Partnership (Limited Partnership), China Construction Bank (601939) Co., Ltd.-Yinhe Pharmaceutical Health mixed Securities Investment Fund, Societe Generale Securities (601377) Co., Ltd., China Construction Bank Co., Ltd.-Xinao Pharmaceutical Health mixed Securities Investment Fund, Hong Kong Securities Clearing Limited The shareholding ratios are 35.17%, 18.12%, 11.25%, 9.47%, 8.41%, 3.55%, 0.39%, 0.38%, 0.22% and 0.21%, respectively.

The above content has nothing to do with the data, has nothing to do with the position of the cloud channel in the interface, and does not constitute investment advice. Operate accordingly at your own risk.